跳到正文
Environmental Science & Technology· Xie·· 7 天前AI 评分31

用类器官与器官芯片模型推进微塑料和纳米塑料的动态生物界面毒理学(综述)

Toward Dynamic Biointerface Toxicology of Micro- and Nanoplastics Using Organoids and Organ-on-a-Chip Models

AI 导读

这篇综述提出以“暴露身份”(exposure identity)为分析框架,把颗粒的环境转化、生物分子吸附、聚集与化学释放同其与组织的接触及后续过程联系起来,并评估类器官与器官芯片模型的相关证据,区分直接的MNP发现与类似物研究及平台能力演示。

AI 深度导读基于原文整理的分节解读
背景
微纳塑料的毒性取决于颗粒接触生物组织时的暴露条件,仅凭名义材料描述无法厘清这些条件。环境转化、生物分子吸附、聚集和化学释放都可能改变颗粒的递送与生物相互作用。
做法
这篇综述评估上述过程,同时梳理类器官与器官芯片模型的证据,并把直接的微纳塑料研究结果、类似物研究与平台能力演示区分开来。作者提出以暴露身份作为分析框架,把颗粒历史与状态同组织接触及时序加工联系起来。
结论
综述梳理现有研究在组织可及性、屏障响应、远端传递和易感性方面已确立的内容,并指出哪些解释仍受暴露表征或机制未明的限制。作者强调,人源模型虽可研究组织特异性响应,但生物复杂性或灌流本身并不能确立环境代表性或预测效度。
意义
文章列出区分颗粒转移、化学释放与组织来源信号,以及解释无效应和评估异质暴露所需的测量与控制要求。优先事项包括可溯源的递送剂量测量、暴露与响应同步采样、针对性机制检验,以及针对明确用途的独立验证;框架对推广到人体暴露与健康结局仍保留不确定性。

原文摘要

出版方登记 · Crossref

Micro- and nanoplastic (MNP) toxicity depends on the exposure conditions under which particles encounter biological tissues, yet nominal material descriptors alone do not resolve these conditions. Environmental transformation, biomolecular adsorption, aggregation, and chemical release can alter particle delivery and biological interactions. This Review evaluates these processes alongside evidence from organoids and organ-on-a-chip models, distinguishing direct MNP findings from analogue studies and demonstrations of platform capability. We propose exposure identity as an analytical framework connecting particle history and state with tissue encounter and subsequent processing over time. The synthesis examines what available studies establish about tissue access, barrier responses, distal relay, and susceptibility, and where interpretation remains constrained by exposure characterization or unresolved mechanisms. Human-derived models provide opportunities to investigate tissue-specific responses, but neither biological complexity nor perfusion establishes environmental representativeness or predictive validity. We identify measurement and control requirements for separating particle transfer from chemical release and tissue-derived signaling, interpreting absent effects, and evaluating heterogeneous exposures. Priorities include traceable delivered-dose measurements, synchronized exposure and response sampling, targeted mechanistic tests, and independent validation for a defined use. The proposed framework organizes evidence and testable relationships while retaining uncertainty about generalization to human exposure and health outcomes.

页面未能读取全文,以上为出版方登记的摘要;方法与图表见原文

本页是 AI 精读,不转载论文原文;完整论文(含方法、图表与参考文献)见原文

来源:Environmental Science & Technology · doi.org